JP2012513471A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513471A5
JP2012513471A5 JP2011543615A JP2011543615A JP2012513471A5 JP 2012513471 A5 JP2012513471 A5 JP 2012513471A5 JP 2011543615 A JP2011543615 A JP 2011543615A JP 2011543615 A JP2011543615 A JP 2011543615A JP 2012513471 A5 JP2012513471 A5 JP 2012513471A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
item
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011543615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012513471A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068989 external-priority patent/WO2010075280A2/en
Publication of JP2012513471A publication Critical patent/JP2012513471A/ja
Publication of JP2012513471A5 publication Critical patent/JP2012513471A5/ja
Pending legal-status Critical Current

Links

JP2011543615A 2008-12-22 2009-12-21 アルツハイマー病および癌の治療のためのクマリン系化合物 Pending JP2012513471A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13983008P 2008-12-22 2008-12-22
US61/139,830 2008-12-22
US25581909P 2009-10-28 2009-10-28
US61/255,819 2009-10-28
PCT/US2009/068989 WO2010075280A2 (en) 2008-12-22 2009-12-21 Coumarin-based compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014196911A Division JP2015038103A (ja) 2008-12-22 2014-09-26 アルツハイマー病および癌の治療のためのクマリン系化合物

Publications (2)

Publication Number Publication Date
JP2012513471A JP2012513471A (ja) 2012-06-14
JP2012513471A5 true JP2012513471A5 (https=) 2013-01-31

Family

ID=41785813

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011543615A Pending JP2012513471A (ja) 2008-12-22 2009-12-21 アルツハイマー病および癌の治療のためのクマリン系化合物
JP2014196911A Pending JP2015038103A (ja) 2008-12-22 2014-09-26 アルツハイマー病および癌の治療のためのクマリン系化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014196911A Pending JP2015038103A (ja) 2008-12-22 2014-09-26 アルツハイマー病および癌の治療のためのクマリン系化合物

Country Status (6)

Country Link
US (2) US20110306605A1 (https=)
EP (1) EP2379504A2 (https=)
JP (2) JP2012513471A (https=)
AU (1) AU2009330124A1 (https=)
CA (1) CA2747811A1 (https=)
WO (1) WO2010075280A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2644335C2 (ru) 2010-03-03 2018-02-08 Зе Юниверсити Оф Бритиш Коламбия Эпитоп, специфичный к олигомеру амилоида бета, и антитела
TWI571207B (zh) 2011-06-26 2017-02-21 安麗托克斯公司 用於條件化動物飼料之寒冷天氣調配物
CN104093454A (zh) * 2011-11-10 2014-10-08 坎格尼美国股份有限公司 治疗阿耳茨海默氏病的组合物和方法
CN102584841B (zh) * 2011-12-16 2014-11-12 浙江工业大学 一种喹啉香豆素衍生物及其制备方法及用途
CN102731458B (zh) * 2012-07-12 2014-03-26 中国科学院南海海洋研究所 双异戊烯基香豆素及其制备方法和应用
CN105884681A (zh) * 2014-10-24 2016-08-24 江苏师范大学 一种聚乙二醇中吡啶衍生物的合成方法
CN104529987B (zh) * 2014-12-04 2016-08-10 中国人民解放军第四军医大学 一类4-羟基双香豆素类化合物及其应用
JP6509079B2 (ja) * 2015-08-27 2019-05-08 株式会社ファンケル ヘリピロンAを有効成分とするPGC1α産生促進剤
CN108774204A (zh) * 2018-06-13 2018-11-09 中国人民解放军第四军医大学 3,3′-(3,5二氟苯亚甲基)-双-4-羟基香豆素及其应用
CN112898278B (zh) * 2019-11-19 2022-05-13 广东医科大学 Sigma-2荧光配体的制备及应用
CN111848565B (zh) * 2020-07-24 2023-01-31 华润三九医药股份有限公司 单萜基双香豆素类化合物、药物组合物及其制备方法和用途
CN112645922B (zh) * 2020-12-24 2022-01-07 中国人民解放军空军军医大学 香豆素类化合物、制备方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3801M (fr) * 1963-10-31 1966-01-03 Denys Monnier Nouveaux médicaments anti-coagulants.
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
EP0770397B1 (en) 1995-10-18 2004-04-21 Akzo Nobel N.V. Newcastle disease virus combination vaccine
WO2003029237A1 (en) * 2001-10-01 2003-04-10 Pliva, Farmaceutska Industrija, Dionicko Drustvo Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
US20060035245A1 (en) * 2004-04-20 2006-02-16 Ason Brandon L Modulators of enzymatic nucleic acid elements mobilization
US20080153872A1 (en) * 2005-01-14 2008-06-26 Mladen Mercep Bis-(Coumarin) Compounds With Anti-Inflammatory Activity
EP1803809A3 (en) * 2005-08-12 2007-12-19 Abgenomics Corporation Modulation of peroxisome proliferator-activated receptors
US20090124688A1 (en) * 2006-01-06 2009-05-14 Rong-Hwa Lin Prostaglandin reductase inhibitors
US20100029654A1 (en) * 2006-03-23 2010-02-04 Mount Sinai School Of Medicine Cardiovascular compositions and use of the same for the treatment of alzheimer's disease

Similar Documents

Publication Publication Date Title
JP2012513471A5 (https=)
JP2019516739A5 (https=)
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
JP2007505877A5 (https=)
JP2010501584A5 (https=)
JP2011505356A5 (https=)
JP2021519263A5 (https=)
JP2003532731A5 (https=)
JP2012144574A5 (https=)
JP2009533356A5 (https=)
JP2014510149A5 (https=)
RU2010126056A (ru) Органические соединения
JP2004534850A5 (https=)
JP2012504133A5 (https=)
JP2019507111A5 (https=)
JP2006507220A5 (https=)
JP2017526677A5 (https=)
JP2015535247A5 (https=)
JP2013542992A5 (https=)
JP2016522254A5 (https=)
JP2006519852A5 (https=)
RU2008139195A (ru) Замещенные арилсульфанамиды как противовирусные средства
JP2013538213A5 (https=)
JP2020505354A5 (https=)
JP2019519593A5 (https=)